Top compounds associated with response to FCER1G

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	ruxolitinib	CTRPv2	pan-cancer	AAC	0.088	0.01
mRNA	BRD1812	CTRPv2	pan-cancer	AAC	0.09	0.01
mRNA	decitabine:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.079	0.01
mRNA	simvastatin	CTRPv2	pan-cancer	AAC	0.1	0.01
mRNA	A-770041	GDSC1000	pan-cancer	AAC	-0.14	0.01
mRNA	VER-155008	CTRPv2	pan-cancer	AAC	0.091	0.01
mRNA	CD-437	CTRPv2	pan-cancer	AAC	0.081	0.01
mRNA	sirolimus:bortezomib (250:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.085	0.01
mRNA	selumetinib:navitoclax (8:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.09	0.01
mRNA	Bryostatin 1	FIMM	pan-cancer	AAC	0.48	0.02

Download CSV